Dearborn Partners Invests $9.74 Million in Gilead Sciences Shares
Dearborn Partners LLC bought 69,875 shares of Gilead Sciences valued at about $9,738,000. Other large holders also increased stakes, including State Street and Bank of America. Director Anthony Welters sold 18,000 shares, and the company declared a quarterly dividend to be paid September 29. Gilead shares rose 0.5%.